Roche, Ainnova, and Salud 360 signed this alliance to improve access to vision screening in patients with uncontrolled diabetes.

see the rationale section on information that should be available to all people involved in the care of people with diabetic retinopathy . Full details of the evidence and the committee's discussion ...

Fourier-domain optical coherence tomography (OCT) was used to image the three-dimensional (3D) structures of the proliferative membrane in proliferative diabetic retinopathy. The case of a 51-year-old ...

Abnormal expression of serum Ephrin-A1 and CTRP9 in diabetic retinopathy patients. In addition, serum Ephrin-A1 in proliferative diabetic retinopathy patients was higher than that in non-proliferative ...

DR was graded according to early Treatment Diabetic Retinopathy (ETDRS ... (70.35%), which included 34 patients (17.1%) with mild non proliferative DR (NPDR), 34 patients (17.1%) with moderate ...

Aims To investigate the relationship between choriocapillaris (CC) blood perfusion and the severity of diabetic retinopathy (DR ... with the differences of 1.61% (95% CI 1.04 to 2.18; p<0.001) among ...

Diabetic retinopathy (DR) is prevalent among people with long-term diabetes mellitus (DM) and remains the leading cause of visual impairment in working-aged people. DR is related to chronic low-level ...

Kodiak Sciences Inc. (NASDAQ:KOD – Get Free Report) was the target of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling ...

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month ...